To make the most of your R&D investment, you need to understand the full commercial potential of your drug product or platform technology as well as what must be done to reach each successive valuation milestone. The development path that must be navigated can be treacherous unless key problems are anticipated and a well-conceived plan is in place to direct successful execution of the program.

PharmaDirections works with venture firms and company founders to determine how early stage opportunities can best be positioned to maximize value, examining existing data for critical gaps while anticipating the scientific gaps and drug development pitfalls that might unnecessarily delay or stop programs before their full value can be realized. 

By drawing on decades of practical drug development experience, from drug discovery to commercial launch, PharmaDirections provides a critical view that can translate lab findings and development opportunities into successful drug products ready for acquisition or exit.